Lifestance Health Group Inc當前公司基本面數據相對非常健康,增長潛力很大。當前估值合理,在醫療服務供應商行業排名3/78位。機構持股佔比非常高,近一個月多位分析師給出公司評級為買入。最高目標價8.50。中期看,股價處於上升通道。近一個月,市場表現較強,技術面和基本面綜合得分較高,較強的走勢獲得基本面和技術面的印證。目前股價在壓力位和支撐位之間,可以做區間波段操作。
Lifestance Health Group Inc評分
相關信息
行業排名
3 / 78
全市場排名
41 / 4582
所屬行業
醫療服務供應商
壓力支撐
由於公司未披露,未能獲取相關數據
多維評測
本期評分
上期評分
分析師目標
基於
10
分析師
買入
評級
8.500
目標均價
+32.61%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議
Lifestance Health Group Inc亮點
亮點風險
LifeStance Health Group, Inc. is a reimagining mental health company. The Company is focused on providing virtual and in-person outpatient mental healthcare for children, adolescents and adults experiencing a variety of mental health conditions. Its patient-focused platform combines differentiated clinical capabilities with a personalized, digitally powered patient experience designed to transform patient access and treatment. Its clinicians offer patients a comprehensive, multidisciplinary suite of mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders and post-traumatic stress disorder. It employs approximately 7,400 psychiatrists, advanced practice nurses, psychologists and therapists and operates across 33 states and more than 550 centers.
LifeStance Health Group, Inc. is a reimagining mental health company. The Company is focused on providing virtual and in-person outpatient mental healthcare for children, adolescents and adults experiencing a variety of mental health conditions. Its patient-focused platform combines differentiated clinical capabilities with a personalized, digitally powered patient experience designed to transform patient access and treatment. Its clinicians offer patients a comprehensive, multidisciplinary suite of mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders and post-traumatic stress disorder. It employs approximately 7,400 psychiatrists, advanced practice nurses, psychologists and therapists and operates across 33 states and more than 550 centers.
公司代碼LFST
公司Lifestance Health Group Inc
CEOBourdon (David)
網址https://investor.lifestance.com/
常見問題
Lifestance Health Group Inc(LFST)的當前股價是多少?
Lifestance Health Group Inc(LFST)的當前股價是 7.050。
Lifestance Health Group Inc 的股票代碼是什麼?
Lifestance Health Group Inc的股票代碼是LFST。
Lifestance Health Group Inc股票的52週最高點是多少?
Lifestance Health Group Inc股票的52週最高點是8.295。
Lifestance Health Group Inc股票的52週最低點是多少?
Lifestance Health Group Inc股票的52週最低點是3.740。
Lifestance Health Group Inc的市值是多少?
Lifestance Health Group Inc的市值是2.74B。
Lifestance Health Group Inc的淨利潤是多少?
Lifestance Health Group Inc的淨利潤為-57.44M。
現在Lifestance Health Group Inc(LFST)的股票是買入、持有還是賣出?
根據分析師評級,Lifestance Health Group Inc(LFST)的總體評級為買入,目標價格為8.500。
Lifestance Health Group Inc(LFST)股票的每股收益(EPS TTM)是多少
Lifestance Health Group Inc(LFST)股票的每股收益(EPS TTM)是-0.024。